在铁缺乏症患者中使用铁克斯或铁克西托尔进行亲肠替代疗法
International journal of clinical pharmacology and therapeutics
|December 30, 2025
概括
在铁缺乏症患者中,用铁克斯或铁克西托尔进行的铁替代疗法显示出类似的疗效和安全性. 血液学参数在两种静脉注射铁配方之间没有显著差异.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 缺铁是一种常见的疾病,需要有效的替代疗法.
- 静脉注射 (IV) 铁制剂,如铁和铁氧醇,用于治疗缺铁性贫血.
研究的目的:
- 为了比较铁替代疗法后血液学参数的变化.
- 为了评估铁德克斯与铁克西托尔在铁缺乏症患者的疗效和安全性.
主要方法:
- 对246名铁缺乏症患者的回顾性审查.
- 患者接受了一次IV输注铁曲 (1,025毫克) 或铁氧醇 (1,020毫克).
- 血液学参数在基线和输注后2-3个月被评估.
主要成果:
- 铁右和铁氧都显著增加了血红蛋白和费里丁水平 (p < 0.0001).
- 两种配方之间在血红蛋白,费里丁,转激素和度,MCV或RDW的变化方面没有观察到统计学上显著的差异.
- 输血反应率在铁甲 (1.4%) 和铁 (3%) (p = 0.65) 之间是相似的.
结论:
- 铁和铁氧醇在改善缺铁患者的血液学参数方面表现出相似的疗效.
- 这两种静脉注射铁配方的安全性是相似的.
- 相当剂量的铁和铁可被认为可以替代IV铁替代疗法.
相关概念视频
The Early Endosome: Endocytosis of Transferrin
4.6K
Essential proteins such as insulin or low-density lipoprotein (LDL) and micronutrients such as iron enter a eukaryotic cell through receptor-mediated endocytosis. Subsequently, the early endosomes fuse with the vesicles containing such receptor-ligand complexes and play a vital role in sorting the incoming ligands and receptors. While the ligands are either degraded inside the vesicle or released into the cytosol, their receptors are returned to the plasma membrane for further rounds of...
4.6K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
171
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
171
Heart Failure VI: Adjunct Therapies
228
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
228
Parentral Nutrition: Centeral and Peripheral Parental Nutrition
676
Parenteral Nutrition (PN) delivers essential nutrients directly into the bloodstream, bypassing the digestive system. It is commonly used for individuals with severe digestive disorders or conditions that prevent normal nutrient absorption.
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
PN can be administered through two primary routes:
1. Central Parenteral Nutrition (CPN):
CPN involves delivering a high concentration of nutrients through a large vein. This is typically achieved using a Peripherally Inserted Central Catheter (PICC) or,...
676
Erythropoiesis
5.6K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.6K


